0
Applied AI·September 10, 2026·1 min read

Would you buy stock in a company whose own scientists think the product might kill you?

Share

Internal safety dissent—like a former Anthropic employee saying labs are “gambling with our lives”—is moving from niche forums into mainstream investor discourse. Boards and CFOs should expect AI risk questions on earnings calls and diligence, and preemptively tighten how they document, govern, and communicate safety posture.